• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Correction to Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.对“冒烟型或多发性骨髓瘤患者中I型戈谢病的患病率：前瞻性观察性CHAGAL研究结果”的勘误
Hemasphere. 2025 May 14;9(5):e70142. doi: 10.1002/hem3.70142. eCollection 2025 May.
2
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.冒烟型或多发性骨髓瘤患者中I型戈谢病的患病率：前瞻性观察性CHAGAL研究结果
Hemasphere. 2025 Jan 22;9(1):e70079. doi: 10.1002/hem3.70079. eCollection 2025 Jan.
3
Regression of smoldering myeloma with treatment of Gaucher disease.戈谢病治疗后冒烟型骨髓瘤的消退
Blood Adv. 2024 Apr 9;8(7):1634-1638. doi: 10.1182/bloodadvances.2023012304.
4
Synchronous multiple myeloma and Gaucher disease.同步性多发性骨髓瘤与戈谢病。
Hematol Oncol Stem Cell Ther. 2020 Mar;13(1):42-45. doi: 10.1016/j.hemonc.2019.07.001. Epub 2019 Oct 9.
5
Effects of Amyloid Light-Chain Amyloidosis on Clinical Characteristics and Prognosis in Multiple Myeloma: A Single-Center Retrospective Study.淀粉样轻链淀粉样变性对多发性骨髓瘤临床特征及预后的影响：一项单中心回顾性研究
Cancer Manag Res. 2021 Feb 11;13:1343-1356. doi: 10.2147/CMAR.S287922. eCollection 2021.
6
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).四个基因可预测无症状多发性骨髓瘤进展为有症状多发性骨髓瘤的高风险（SWOG S0120）。
Haematologica. 2015 Sep;100(9):1214-21. doi: 10.3324/haematol.2015.124651. Epub 2015 May 28.
7
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.卡非佐米、来那度胺和地塞米松治疗后序贯来那度胺维持治疗高危冒烟型骨髓瘤患者预防症状性多发性骨髓瘤的Ⅱ期非随机对照试验
JAMA Oncol. 2021 Nov 1;7(11):1678-1685. doi: 10.1001/jamaoncol.2021.3971.
8
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma.高危冒烟型骨髓瘤患者的基线突变模式与持续微小残留病阴性
Blood Adv. 2017 Sep 29;1(22):1911-1918. doi: 10.1182/bloodadvances.2017005934. eCollection 2017 Oct 10.
9
High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implications.高危冒烟型骨髓瘤与多发性骨髓瘤的早期检测：当前模型、治疗目标及临床意义。
Best Pract Res Clin Haematol. 2020 Mar;33(1):101152. doi: 10.1016/j.beha.2020.101152. Epub 2020 Jan 25.
10
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.浆细胞异常增生中缺失 13 获得的时间取决于遗传背景。
Haematologica. 2009 Dec;94(12):1708-13. doi: 10.3324/haematol.2009.011064.

对“冒烟型或多发性骨髓瘤患者中I型戈谢病的患病率：前瞻性观察性CHAGAL研究结果”的勘误

Correction to Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.

出版信息

Hemasphere. 2025 May 14;9(5):e70142. doi: 10.1002/hem3.70142. eCollection 2025 May.

DOI:10.1002/hem3.70142
PMID:40370360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12076056/
Abstract

[This corrects the article DOI: 10.1002/hem3.70079.].

摘要

[本文更正了文章的数字对象标识符：10.1002/hem3.70079。]